CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.
Fromentin R, Bakeman W, Lawani MB, Khoury G, Hartogensis W, DaFonseca S, Killian M, Epling L, Hoh R, Sinclair E, Hecht FM, Bacchetti P, Deeks SG, Lewin SR, Sékaly RP, Chomont N. · 2016
Read CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART. by Fromentin R, Bakeman W, Lawani MB, Khoury G, Hartogensis W, DaFonseca S, Killian M, Epling L, Hoh R, Sinclair E, Hecht FM, Bacchetti P, Deeks SG, Lewin SR, Sékaly RP, Chomont N. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4944956.txt.
Description
Rémi Fromentin leads a large team hunting surface markers on the cells where HIV hides during treatment. Their study appeared in PLoS Pathogens in 2016. Antiretroviral therapy holds the virus down, but a small pool of latently infected cells survives for years. The team guessed that cells wearing immune checkpoint molecules, brakes on immune attack, would hold more of that hidden virus. They tested seven checkpoint markers in blood from 48 people whose virus was fully suppressed.
Three markers tracked with hidden HIV. Cells expressing PD-1, TIGIT, or LAG-3 held more integrated viral DNA. Cells wearing all three predicted reservoir size on their own. Sorted cell tests confirmed the enrichment. The authors argue the markers give cure research a handle. If the hiding cells can be picked out by surface flags, future strategies may reach and clear them.
Catalog record
| CREATOR | Fromentin R, Bakeman W, Lawani MB, Khoury G, Hartogensis W, DaFonseca S, Killian M, Epling L, Hoh R, Sinclair E, Hecht FM, Bacchetti P, Deeks SG, Lewin SR, Sékaly RP, Chomont N. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |